GSA Capital Partners’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34K | Buy |
+81,326
| New | +$34K | ﹤0.01% | 1677 |
|
|
2024
Q4 | – | Sell |
-48,204
| Closed | -$88K | – | 1576 |
|
|
2024
Q3 | $88K | Buy |
+48,204
| New | +$88K | 0.01% | 1501 |
|
|
2024
Q2 | – | Sell |
-10,289
| Closed | -$115K | – | 1595 |
|
|
2024
Q1 | $115K | Buy |
+10,289
| New | +$115K | 0.01% | 1476 |
|
|
2023
Q3 | – | Sell |
-12,730
| Closed | -$96K | – | 1465 |
|
|
2023
Q2 | $96K | Buy |
+12,730
| New | +$96K | 0.01% | 1380 |
|
|
2022
Q4 | – | Sell |
-16,114
| Closed | -$154K | – | 1431 |
|
|
2022
Q3 | $154K | Buy |
+16,114
| New | +$154K | 0.02% | 1289 |
|
|
2022
Q1 | – | Sell |
-24,203
| Closed | -$520K | – | 1377 |
|
|
2021
Q4 | $520K | Buy |
+24,203
| New | +$520K | 0.07% | 574 |
|